I now have comprehensive information from multiple authoritative neurology textbooks. Let me compile a thorough, well-organized answer.
Conditions Causing Hypotonia
Hypotonia (decreased resistance of muscles to passive manipulation - the "floppy" state) results from lesions at any level from the cerebral cortex down to the muscle itself. The anatomical level of the lesion determines the clinical pattern.
Key Clinical Distinction: Central vs. Peripheral Hypotonia
| Feature | Central (Upper Motor Neuron) | Peripheral (Lower Motor Neuron / NMJ / Muscle) |
|---|
| Weakness | Axial > appendicular | Profound, often appendicular |
| Reflexes | Preserved or increased over time | Absent or reduced |
| Alertness | Often impaired | Alert, awake |
| CK | Normal | Normal to markedly elevated |
| Other | Dysmorphic features common | Fasciculations (SMA) |
Central disorders are far more common causes of hypotonia than motor unit diseases. - Bradley and Daroff's Neurology in Clinical Practice
I. Central (Cerebral) Hypotonia
Lesions at the cerebral hemisphere level produce hypotonia disproportionate to the degree of weakness, often with concurrent axial hypotonia + appendicular hypertonia.
A. Chromosomal Disorders
- Prader-Willi Syndrome (PWS) - absence of paternally expressed genes on chromosome 15q; profound hypotonia, poor feeding; normal CK, EMG, and muscle biopsy. Diagnosed by DNA methylation analysis (targets SNURF-SNRPN locus).
- Down Syndrome (Trisomy 21) - hypotonia is a cardinal feature
- Angelman Syndrome - chromosome 15 imprinting disorder
- Other microdeletion/microduplication syndromes (detected by array CGH)
B. Perinatal Brain Injury
- Hypoxic-ischemic encephalopathy (HIE) - most common acquired cause of neonatal hypotonia; acquired perinatal injury is far more common than inherited disorders
- Periventricular leukomalacia
- Intracranial hemorrhage
C. Chronic Nonprogressive Encephalopathy (Cerebral Palsy)
- Cerebral dysgenesis related to genetic disorder
- In utero infection (TORCH)
- Toxic exposure
- Inborn error of metabolism
- Vascular insult
D. Cerebellar Disease
Loss of the deep cerebellar nuclei (particularly dentate and interposed nuclei) causes hypotonia on the ipsilateral side. The mechanism is loss of cerebellar facilitation of motor cortex and brainstem motor nuclei by tonic signals. Hypotonia is more apparent in acute than chronic cerebellar lesions. - Guyton and Hall Medical Physiology, Adams and Victor's Neurology
E. Metabolic / Endocrine
- Hypothyroidism - TSH should be checked in any infant with hypotonia
- Peroxisomal disorders (Zellweger syndrome, neonatal adrenoleukodystrophy)
- Mitochondrial disorders
II. Combined Cerebral and Motor Unit Disorders
These conditions affect both the CNS and the peripheral neuromuscular system:
| Condition | Key Features |
|---|
| Acid maltase deficiency (Pompe disease) | Lysosomal glycogen accumulation; severe skeletal myopathy + cardiomyopathy + encephalopathy; diagnosed by acid α-1,4-glucosidase assay; enzyme replacement available |
| Congenital Myotonic Dystrophy | Autosomal dominant (DMPK trinucleotide repeat); ~25% of infants of affected mothers; profound hypotonia + facial weakness; survivors develop myotonia at puberty |
| Syndromic Congenital Muscular Dystrophies | Defects of O-glycosylation of dystroglycan; Fukuyama CMD, Walker-Warburg syndrome, muscle-eye-brain disease; hypotonia + epilepsy + cobblestone lissencephaly + ocular defects |
| Congenital Disorders of Glycosylation | Type Ia (phosphomannomutase deficiency) most common; hypotonia + hyporeflexia + inverted nipples + abnormal fat distribution |
| Lysosomal Disorders | Multiple types |
| Infantile Neuroaxonal Dystrophy | PLA2G6 mutations |
III. Spinal Cord Disorders
| Condition | Key Features |
|---|
| Spinal Muscular Atrophy (SMA) | Anterior horn cell degeneration; SMN1 deletion; types I-IV; now in newborn screening; tongue fasciculations, paradoxical breathing |
| X-linked SMA | UBE1 mutations |
| Infantile SMA with Respiratory Distress | IGHMBP2 mutations |
| Acquired Spinal Cord Lesions | Trauma, cord compression, ischemia |
IV. Peripheral Nerve Disorders
| Condition | Key Features |
|---|
| Congenital Hypomyelinating Neuropathy / Dejerine-Sottas Disease | Severe demyelinating neuropathy; absent reflexes; elevated CSF protein; nerve conduction severely reduced |
| Charcot-Marie-Tooth disease (congenital) | Hereditary motor and sensory neuropathy |
| Hereditary neuropathies | Various types |
V. Neuromuscular Junction (NMJ) Disorders
| Condition | Key Features |
|---|
| Neonatal (Transient) Myasthenia Gravis | Maternal anti-AChR antibodies; resolves within weeks |
| Juvenile Myasthenia Gravis | Autoimmune; anti-AChR or anti-MuSK antibodies; ptosis, fatigable weakness |
| Congenital Myasthenic Syndromes | Genetic defects in NMJ components; antibody-negative |
| Infant Botulism | Clostridium botulinum toxin; descending flaccid paralysis, constipation, ophthalmoplegia; ocular palsies and apnea are late signs |
VI. Muscle Disorders (Myopathies)
Congenital Myopathies (structural)
- Central core disease - RYR1 mutations; malignant hyperthermia risk
- Nemaline (rod) myopathy - nemaline rods on Gomori trichrome stain
- Centronuclear (myotubular) myopathy - X-linked or AD/AR; centrally placed nuclei
Congenital Muscular Dystrophies
- Merosin-deficient CMD (laminin α2 deficiency, LAMA2 mutations) - white matter abnormalities on MRI
- Ullrich CMD - collagen VI deficiency; distal joint hyperlaxity + proximal contractures
- Infantile Facioscapulohumeral Dystrophy - D4Z4 repeat contraction; may have cognitive impairment, epilepsy, hearing loss
Other Muscle Conditions
- Metabolic myopathies - glycogen storage diseases, lipid myopathies
- Mitochondrial myopathies - elevated lactate/pyruvate ratio
Diagnostic Approach Summary
Hypotonia
│
├── Central signs (encephalopathy, seizures, dysmorphic features)?
│ → Brain MRI, karyotype/array CGH, metabolic screen, TSH
│
└── Peripheral signs (alert, areflexia, weakness)?
→ Serum CK
├── Normal/mildly elevated → EMG/NCS
│ ├── Neuropathic → SMA (SMN1 deletion), nerve biopsy
│ ├── Myopathic → Muscle biopsy, gene panel
│ └── NMJ pattern → AChR antibodies, repetitive nerve stim
└── Markedly elevated → Muscular dystrophy, myopathy
Key workup tests: serum CK, TSH, lactate/pyruvate, array CGH, SMN1 deletion analysis (SMA), EMG/NCS, muscle biopsy, brain MRI, AChR/MuSK antibodies, enzyme assays (Pompe), whole exome sequencing when above negative.
Sources: Bradley and Daroff's Neurology in Clinical Practice; Adams and Victor's Principles of Neurology, 12th ed.; Guyton and Hall Textbook of Medical Physiology; The Harriet Lane Handbook, 23rd ed.